1. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. (March 2023) Authors: Liou, Jyh-Ming; Jiang, Xiao-Tao; Chen, Chieh-Chang; Luo, Jiing-Chyuan; Bair, Ming-Jong; Chen, Po-Yueh; Chou, Chu-Kuang; Fang, Yu-Jen; Chen, Mei-Jyh; Chen, Chien-Chuan; Lee, Ji-Yuh; Yang, Tsung-Hua; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chen, Chi-Yi; Shun, Chia-Tung; Hu, Wen-Hao; Tsai, Mi... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 3(2023) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗